Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccinations

Vaccinations

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Intramuscular and intradermal injection of DNA vaccines in mice and primates.

Methods in molecular medicine·2011

Same author

DNA-Based Immunization of Neonatal Mice.

Methods in molecular medicine·2011

Same author

Intramuscular injection of DNA vaccines in fish.

Methods in molecular medicine·2011

Same author

Immunostimulatory CpG motifs and DNA vaccines.

Methods in molecular medicine·2011

Same author

CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2008

Same author

Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNA.

Current topics in microbiology and immunology·2006

Same journal

Erratum to: Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination.

Methods in molecular medicine·2015

Same journal

Methods for cancer gene therapy using tumor suppressor genes.

Methods in molecular medicine·2014

Same journal

Suppression of the human carcinoma phenotype by an antioncogene ribozyme.

Methods in molecular medicine·2014

Same journal

Methods for the use of stromal cells for therapeutic gene therapy.

Methods in molecular medicine·2014

Same journal

Methods for adenovirus-mediated gene transfer to synovium in vivo.

Methods in molecular medicine·2014

Same journal

Methods for gene transfer to synovium.

Methods in molecular medicine·2014

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Skin Tattooing As A Novel Approach For DNA Vaccine Delivery

Skin Tattooing As A Novel Approach For DNA Vaccine Delivery

Published on: October 18, 2012

Mucosal immunization with DNA vaccines.

M J McCluskie¹, H L Davis

¹Loeb Research Institute, Ottawa Civic Hospital, Ottawa, Canada.

Methods in Molecular Medicine

|March 5, 2011

Summary

This summary is machine-generated.

Mucosal vaccines, delivered to the gastrointestinal, genitourinary, or respiratory tracts, are more effective than systemic vaccines. They induce both local and systemic immunity, offering a safer, non-invasive alternative for disease prevention.

More Related Videos

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Published on: October 30, 2018

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Published on: January 20, 2019

Related Experiment Videos

Last Updated: Jun 3, 2026

Skin Tattooing As A Novel Approach For DNA Vaccine Delivery

Skin Tattooing As A Novel Approach For DNA Vaccine Delivery

Published on: October 18, 2012

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Published on: October 30, 2018

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Published on: January 20, 2019

Area of Science:

Immunology
Vaccinology
Public Health

Background:

Mucosal surfaces (gastrointestinal, genitourinary, respiratory) have a large surface area, making them primary sites for disease transmission.
Pathogen entry at mucosal sites requires mucosal immunity for prevention, which systemic immunity cannot provide.
Traditional intramuscular (IM) or subcutaneous (SC) vaccines primarily induce systemic immunity, neglecting mucosal protection.

Purpose of the Study:

To highlight the advantages of mucosal vaccines over systemic vaccines.
To emphasize the role of mucosal immunity in preventing infections at mucosal surfaces.
To advocate for the development and use of mucosal vaccine delivery methods.

Main Methods:

Review of existing literature on vaccine delivery routes and immune responses.
Comparison of immune responses elicited by mucosal versus systemic vaccine administration.
Analysis of safety and logistical benefits of mucosal immunization.

Main Results:

Mucosal vaccine delivery triggers both local and distant mucosal immunity, as well as systemic immunity.
Intramuscular (IM) or subcutaneous (SC) injections primarily induce systemic immunity, with limited mucosal protection.
Mucosal vaccines offer advantages like broader age applicability, ease of administration, and no risk of needle-related injuries.

Conclusions:

Mucosal immunization is a superior strategy for preventing diseases transmitted via mucosal surfaces.
Developing and implementing mucosal vaccines can enhance protection against a wide range of pathogens.
The non-invasive nature and broader benefits make mucosal vaccines a promising approach for future immunization programs.